NCT01414413

Brief Summary

Despite increasing availability of antiretroviral therapy (ART) for HIV in high prevalence countries, the majority of people with HIV infection still initiate treatment at an advanced stage of disease. This leads to a high risk of death soon after HIV diagnosis. Prompt HIV diagnosis is, therefore, necessary for both individual and public health benefit and is being strongly promoted as international and national policy in Malawi. However timely HIV diagnosis may not in itself be sufficient to ensure ART initiation: this is reflected by the relatively high proportion of individuals who defer treatment-seeking for months or years following diagnosis of HIV. Here the researchers investigate the extent to which home assessment and initiation of ART adds to the effectiveness of a home-based HIV testing and counseling strategy, using entry to, adherence with, and retention in HIV care as the outcome of interest.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16,660

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 11, 2011

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
1 year until next milestone

Results Posted

Study results publicly available

April 7, 2014

Completed
Last Updated

April 7, 2014

Status Verified

February 1, 2014

Enrollment Period

10 months

First QC Date

August 10, 2011

Results QC Date

February 19, 2014

Last Update Submit

February 19, 2014

Conditions

Keywords

HIVAIDSAntiretroviral therapyCommunity-based studyCluster-randomised trialHIV testingAfrica

Outcome Measures

Primary Outcomes (1)

  • ART Initiation

    Comparison between study arms of the proportion of all resident adults (per capita, and irrespective of HIV status or participation in home-based HIV testing intervention) who initiate ART during the first 6 months of the home-based HIV-testing intervention.

    First six months following introduction of home-based HIV testing

Secondary Outcomes (5)

  • Uptake of Home-based HIV Testing

    The first 6-months following home assessment and initiation of ART being made available

  • Reporting of HIV-positive Results

    The first 6-months following availability of home-based HIV testing

  • Loss to Retention

    The first 6-months following availability of home-based HIV testing

  • Adherence to ART

    First 6-months following availability of home-based HIV testing

  • Adult Mortality

    The first 6-months following availability of home-based HIV testing

Study Arms (2)

Home assessment and initiation of ART

EXPERIMENTAL

Participants with a positive home-based HIV test result will receive a home visit from a study nurse who will complete the following on the first home visit: * Confirmatory fingerprick HIV testing * TB symptom screening * ART eligibility assessment (Word Health Organization clinical staging, sampling of blood for measurement of CD4 count and treatment education) At a second home visit (within 5 days), participants who are ART eligible (as defined in National ART guidelines) will be initiated onto ART (using National Treatment Programme ART regimens). Following home initiation of ART, participants in the intervention arm will receive detailed counselling from the study nurse about the need to attend their first 2-week follow-up appointment at the primary health care clinic that serves their household's residence. They will receive a referral slip detailing the date, time and place of their appointment.

Other: Home assessment and initiation of ART

Clinic-based ART assessment and initiation

OTHER

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor. HIV care, including ART, will be started from the primary care clinic.

Other: Clinic-based ART assessment and initiation

Interventions

Home-based ART eligibility assessment (WHO staging, CD4 count measurement and educational treatment preparation) and initiation.

Home assessment and initiation of ART

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor.

Clinic-based ART assessment and initiation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Usual resident of an eligible cluster
  • Has had a positive HIV test (regardless of source) and requests facilitated access to HIV care from the resident community counsellor
  • Confirmatory HIV test is positive
  • No previous ART treatment, or less than one month's treatment in the past (including PMTCT interventions) and not currently receiving HIV care
  • No contraindications to receiving ART (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • No acute danger signs requiring hospital referral
  • Aged 18 years or older
  • Written or witnessed informed consent to participate in the study

You may not qualify if:

  • Not a usual resident of an eligible cluster
  • No previous HIV test, or HIV infection not confirmed by home-based ART nurse
  • Already receiving ART, or has had more than 1 month's treatment in the past
  • Known contraindication to firstline ART (known hypersensitivity, renal failure, chronic liver disease)
  • Acute danger sign present (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • Age younger than 18 years
  • Not willing to accept home-based ART initiation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

Blantyre, Chichiri, 3, Malawi

Location

Related Publications (1)

  • MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, Butterworth AE, van Oosterhout JJ, Desmond N, Thindwa D, Squire SB, Hayes RJ, Corbett EL. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014 Jul 23-30;312(4):372-9. doi: 10.1001/jama.2014.6493.

Related Links

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Dr Peter MacPherson
Organization
Liverpool School of Tropical Medicine

Study Officials

  • Peter MacPherson, MBChCB MPH

    Liverpool School of Tropical Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2011

First Posted

August 11, 2011

Study Start

January 1, 2012

Primary Completion

November 1, 2012

Study Completion

April 1, 2013

Last Updated

April 7, 2014

Results First Posted

April 7, 2014

Record last verified: 2014-02

Locations